Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of General and Family Medicine|June 1, 2023
Characteristics of participants in a public rubella antibody testing program conducted at a Japan professional football league venueToshinori Nishizawa, Kuniyoshi Hayashi, Noriyuki Amano, et al.Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2020
[Dermatomyositis-Like Symptoms Useful for Diagnosis of Ureteral Cancer]Megumi Nomura, Takahiro Hirayama, Yusuke Sakata, et al.Urologic Oncology|November 8, 2020
High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomyNoriyuki Amano, Kazumasa Matsumoto, Yuriko Shimizu, et al.Asian Pacific Journal of Cancer Prevention : APJCP|March 27, 2019
Gleason Pattern 5 is a Possible Pathologic Predictor for Biochemical Recurrence after Laparoscopic Radical ProstatectomyMasaomi Ikeda, Noriyuki Amano, Yusuke Sakata, et al.Urologic Oncology|October 19, 2020
PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomyYasukiyo Murakami, Kazumasa Matsumoto, Yuriko Shimizu, et al.Journal of General and Family Medicine|March 15, 2021
A public health collaboration between medical professionals and Japan's professional football league for rubella awarenessToshinori Nishizawa, Yuko Murashima, Yuichi Nakamura, et al.Hinyokika Kiyo. Acta Urologica Japonica|January 22, 2016
[A Case of Emphysematous Pyelonephritis with Pneumoderma Treated by Open Surgical Drainage]Soichiro Shimura, Ken-ichi Tabata, Dai Koguchi, et al.Cancers|March 25, 2022
Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder CancerKohei Mori, Kazumasa Matsumoto, Noriyuki Amano, et al.Cancer Biomarkers : Section a of Disease Markers|November 27, 2018
TROY expression is associated with pathological stage and poor prognosis in patients treated with radical cystectomyMegumi Nomura, Kazumasa Matsumoto, Yuriko Shimizu, et al.Cancers|May 28, 2022
DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder CancerShuhei Hirano, Kazumasa Matsumoto, Kei Tanaka, et al.Pageof 2